High Tower Advisors, LLC Alpha Tau Medical Ltd. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, High Tower Advisors, LLC holds 230,704 shares of DRTS stock, worth $528,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
230,704
Previous 212,508
8.56%
Holding current value
$528,312
Previous $626,000
6.87%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.42MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY280KShares$642,2510.07% of portfolio
-
Hoyle Cohen, LLC269KShares$616,2110.05% of portfolio
-
Corbin Capital Partners, L.P. New York, NY97.2KShares$222,5810.69% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$151,8860.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$122,7570.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $158M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...